Peregrine Pharmaceuticals reported $141.93M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Bristol Myers Squibb BMY:US USD 36.97B 141M
Eli Lilly And LLY:US USD 14.14B 548.2M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Mannkind MNKD:US USD 367.5M 509K
Novartis NOVN:VX USD 21.24B 2.55B
Peregrine Pharmaceuticals PPHM:US USD 141.93M 128K
Roche Holding ROG:VX 22.37B 6.29B